<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00748748</url>
  </required_header>
  <id_info>
    <org_study_id>VERA 437</org_study_id>
    <nct_id>NCT00748748</nct_id>
  </id_info>
  <brief_title>Effect of Lactobacillus Probiotic on Healthy Adults</brief_title>
  <official_title>Effect of Lactobacillus Probiotic on Healthy Adults</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fargo VA Medical Center</agency>
      <agency_class>U.S. Fed</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fargo VA Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Diarrhea is a common side effect of antibiotics; it may prolong hospital stay, increase the
      risk of other infections, develop into more serious forms of disease, and lead to premature
      discontinuation of the needed antibiotic. The purpose of this study is to examine the safety
      and effectiveness of a capsule containing Lactobacillus rhamnosus GG in the prevention of
      diarrhea associated with antibiotic use.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>February 2010</start_date>
  <completion_date type="Actual">April 2012</completion_date>
  <primary_completion_date type="Actual">April 2012</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of diarrhea</measure>
    <time_frame>Approximately one month</time_frame>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Antibiotic-associated Diarrhea</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Lactobacillus rhamnosus GG capsule three times per day while taking their antibiotic(s) and for 7 days following completion of the antibiotic.</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Culturelle</intervention_name>
    <description>10^10 Lactobacillus rhamnosus GG per capsule</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Participants (male or female inpatients) 18 to 64 years of age who are prescribed
             antibiotics (single or multiple antibiotics, oral or intravenous) will be recruited
             from the Fargo VAMC Primary Care Clinic area.

          -  Participants must be able to swallow a capsule.

        Exclusion Criteria:

          -  Exclusion criteria include diarrhea on admission or within the preceding week

          -  Reported recurrent diarrhea

          -  Antibiotics in the past four weeks

          -  Significant underlying conditions (e.g. diabetes, structural cardiac defects including
             valvular defects, history of infective endocarditis, poor cardiac function,
             immunosuppression, impaired gut integrity, moderate or serious intestinal disorders,
             malignancies, pancreatitis, indwelling catheters, recent surgery, recent prolonged
             hospitalization)

          -  Previous bowel surgery

          -  Nutritional restrictions that preclude participation

          -  Hypersensitivity to penicillin G, ampicillin, or erythromycin

          -  Persons who have been prescribed their antibiotic for a duration longer than 3 weeks
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>64 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Fargo VA Medical Center</name>
      <address>
        <city>Fargo</city>
        <state>North Dakota</state>
        <zip>58102</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 8, 2008</study_first_submitted>
  <study_first_submitted_qc>September 8, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 9, 2008</study_first_posted>
  <last_update_submitted>July 3, 2012</last_update_submitted>
  <last_update_submitted_qc>July 3, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 4, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Fargo VA Medical Center</investigator_affiliation>
    <investigator_full_name>Stephanie Borchardt</investigator_full_name>
    <investigator_title>Tze Shien Lo, MD</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diarrhea</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

